paper_id,claim,figure_id,title,caption,local_image_path,url
PMC11062018,"Following the screening process, 36 studies (from 41 publications reporting QoL outcomes in patients with FD) were included in the analysis (Fig. 1A; Table 1A).",PMC11062018_figure_1,Fig. 1.,"PRISMA flow diagram for the studies across the humanistic (a) and economic (b) searches. aDatabases included Embase®, MEDLINE®, Cochrane, PubMed and ProQuest. ProQuest was utilized for initial review conducted in January 2020; for the refresh of the current review (conducted in January 2022) only Embase®, Cochrane, and PubMed were utilized, in line with the protocol. bIn addition to the assessment of QoL, four studies from the economic burden SLR reported utility values with EQ-5D index scale. The EQ-5D results were included in the humanistic burden SLR and the utility values from these studies were included in the economic burden SLR. cFour studies were retrieved from humanistic burden review as a part of bibliography. Some publications contained more than one economic study type; the numbers of publications by type are therefore not mutually exclusive. SGA, subgroup analysis",./data/PMC11062018/images/figure_1.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/c7da233c162a/13023_2024_3131_Fig1_HTML.jpg
PMC11062018,"Five studies evaluated the impact of FD on QoL in different patient populations using the EQ-5D descriptive system [35, 41, 45–47], and domain-specific findings are presented in Fig. 2A.",PMC11062018_figure_2,Fig. 2.,"EQ-5D findings from studies using the descriptive system (a) and the VAS (b). aThe proportion of patients with ‘no problems’ was calculated using a subtractive approach based on the proportions of patients with ‘moderate problems’ or ‘extreme problems’ for Żuraw et al. [41]. b‘Extreme problems’ was expressed as ‘confined to bed’ for all dimensions in in Miners et al. [35] and for the mobility dimension in Polistena et al. [47]. cNo normative population comparator was included for Barba-Romero et al. [46] or Żuraw et al. [41]. Data obtained from Arends et al. [45], Barba-Romero et al. [46], Löhle et al. [33], Low et al. [34], Miners et al. [35], Nowak et al. [48], Polistena et al. [47], Santamaria et al. [49], and Żuraw et al. [41]. Error bars represent standard deviations, where reported",./data/PMC11062018/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/cefa8d892a8a/13023_2024_3131_Fig2_HTML.jpg
PMC11062018,An overview of mean VAS scores is presented in Fig. 2B.,PMC11062018_figure_2,Fig. 2.,"EQ-5D findings from studies using the descriptive system (a) and the VAS (b). aThe proportion of patients with ‘no problems’ was calculated using a subtractive approach based on the proportions of patients with ‘moderate problems’ or ‘extreme problems’ for Żuraw et al. [41]. b‘Extreme problems’ was expressed as ‘confined to bed’ for all dimensions in in Miners et al. [35] and for the mobility dimension in Polistena et al. [47]. cNo normative population comparator was included for Barba-Romero et al. [46] or Żuraw et al. [41]. Data obtained from Arends et al. [45], Barba-Romero et al. [46], Löhle et al. [33], Low et al. [34], Miners et al. [35], Nowak et al. [48], Polistena et al. [47], Santamaria et al. [49], and Żuraw et al. [41]. Error bars represent standard deviations, where reported",./data/PMC11062018/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/cefa8d892a8a/13023_2024_3131_Fig2_HTML.jpg
PMC11062018,"Among the studies comparing scores to a relevant normative population, all reported a significantly lower mean score in the patient population compared with controls (p ≤ 0.02 in all three studies).Impact of patients’ sex and ERT on EQ-5D VAS findings
Three studies evaluated EQ-5D VAS scores according to sex (Fig. 2B), each of which reported a numerically higher mean score in female patients than in male patients: 76.8 versus 72.6, 72 versus 65, and 75.8 versus 69.7 for females versus males across the three studies by Löhle, Żuraw, and Nowak, respectively, although none of these differences between sexes were statistically significant [33, 41, 48]. Żuraw and colleagues also analyzed the impact of ERT on EQ-5D VAS scores [41].",PMC11062018_figure_2,Fig. 2.,"EQ-5D findings from studies using the descriptive system (a) and the VAS (b). aThe proportion of patients with ‘no problems’ was calculated using a subtractive approach based on the proportions of patients with ‘moderate problems’ or ‘extreme problems’ for Żuraw et al. [41]. b‘Extreme problems’ was expressed as ‘confined to bed’ for all dimensions in in Miners et al. [35] and for the mobility dimension in Polistena et al. [47]. cNo normative population comparator was included for Barba-Romero et al. [46] or Żuraw et al. [41]. Data obtained from Arends et al. [45], Barba-Romero et al. [46], Löhle et al. [33], Low et al. [34], Miners et al. [35], Nowak et al. [48], Polistena et al. [47], Santamaria et al. [49], and Żuraw et al. [41]. Error bars represent standard deviations, where reported",./data/PMC11062018/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/cefa8d892a8a/13023_2024_3131_Fig2_HTML.jpg
PMC11062018,"Following the screening process, 18 studies (from 19 publications) were included in the analysis; two studies (from three publications) reported economic evaluations, 11 (from 11 publications) reported cost burden and resource use, and seven (from seven publications) reported utility review (Fig. 1B; Table 1B).",PMC11062018_figure_1,Fig. 1.,"PRISMA flow diagram for the studies across the humanistic (a) and economic (b) searches. aDatabases included Embase®, MEDLINE®, Cochrane, PubMed and ProQuest. ProQuest was utilized for initial review conducted in January 2020; for the refresh of the current review (conducted in January 2022) only Embase®, Cochrane, and PubMed were utilized, in line with the protocol. bIn addition to the assessment of QoL, four studies from the economic burden SLR reported utility values with EQ-5D index scale. The EQ-5D results were included in the humanistic burden SLR and the utility values from these studies were included in the economic burden SLR. cFour studies were retrieved from humanistic burden review as a part of bibliography. Some publications contained more than one economic study type; the numbers of publications by type are therefore not mutually exclusive. SGA, subgroup analysis",./data/PMC11062018/images/figure_1.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/c7da233c162a/13023_2024_3131_Fig1_HTML.jpg
PMC11062018,"Impact of patients’ sex and ERT on EQ-5D VAS findings
Three studies evaluated EQ-5D VAS scores according to sex (Fig. 2B), each of which reported a numerically higher mean score in female patients than in male patients: 76.8 versus 72.6, 72 versus 65, and 75.8 versus 69.7 for females versus males across the three studies by Löhle, Żuraw, and Nowak, respectively, although none of these differences between sexes were statistically significant [33, 41, 48]. Żuraw and colleagues also analyzed the impact of ERT on EQ-5D VAS scores [41].",PMC11062018_figure_2,Fig. 2.,"EQ-5D findings from studies using the descriptive system (a) and the VAS (b). aThe proportion of patients with ‘no problems’ was calculated using a subtractive approach based on the proportions of patients with ‘moderate problems’ or ‘extreme problems’ for Żuraw et al. [41]. b‘Extreme problems’ was expressed as ‘confined to bed’ for all dimensions in in Miners et al. [35] and for the mobility dimension in Polistena et al. [47]. cNo normative population comparator was included for Barba-Romero et al. [46] or Żuraw et al. [41]. Data obtained from Arends et al. [45], Barba-Romero et al. [46], Löhle et al. [33], Low et al. [34], Miners et al. [35], Nowak et al. [48], Polistena et al. [47], Santamaria et al. [49], and Żuraw et al. [41]. Error bars represent standard deviations, where reported",./data/PMC11062018/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/cefa8d892a8a/13023_2024_3131_Fig2_HTML.jpg
PMC11062018,"Three studies evaluated EQ-5D VAS scores according to sex (Fig. 2B), each of which reported a numerically higher mean score in female patients than in male patients: 76.8 versus 72.6, 72 versus 65, and 75.8 versus 69.7 for females versus males across the three studies by Löhle, Żuraw, and Nowak, respectively, although none of these differences between sexes were statistically significant [33, 41, 48]. Żuraw and colleagues also analyzed the impact of ERT on EQ-5D VAS scores [41].",PMC11062018_figure_2,Fig. 2.,"EQ-5D findings from studies using the descriptive system (a) and the VAS (b). aThe proportion of patients with ‘no problems’ was calculated using a subtractive approach based on the proportions of patients with ‘moderate problems’ or ‘extreme problems’ for Żuraw et al. [41]. b‘Extreme problems’ was expressed as ‘confined to bed’ for all dimensions in in Miners et al. [35] and for the mobility dimension in Polistena et al. [47]. cNo normative population comparator was included for Barba-Romero et al. [46] or Żuraw et al. [41]. Data obtained from Arends et al. [45], Barba-Romero et al. [46], Löhle et al. [33], Low et al. [34], Miners et al. [35], Nowak et al. [48], Polistena et al. [47], Santamaria et al. [49], and Żuraw et al. [41]. Error bars represent standard deviations, where reported",./data/PMC11062018/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e49/11062018/cefa8d892a8a/13023_2024_3131_Fig2_HTML.jpg
